scopolamine + chlorpromazine

Scopolamine + chlorpromazine is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Scopolamine is an anticholinergic agent that acts as a competitive antagonist at muscarinic acetylcholine receptors, primarily used to prevent nausea and vomiting associated with motion sickness and postoperative states. Chlorpromazine is a first-generation (typical) antipsychotic that functions mainly as an antagonist at dopamine D2 receptors in the brain, but also blocks other receptor types including histaminergic, adrenergic, and muscarinic receptors. It is used for the treatment of psychotic disorders such as schizophrenia and bipolar disorder, as well as for controlling severe nausea and vomiting, persistent hiccups, preoperative anxiety, porphyria, tetanus adjunct therapy, and behavioral disturbances in children[1][3][5][6][8]. The combination may be considered when both antiemetic (anti-nausea) effects are desired alongside management of psychiatric or neurological symptoms.